Lee, Chang-Soo et al. published their research in Colloids and Surfaces, B: Biointerfaces in 2012 |CAS: 146370-51-6

The Article related to fluorescent nanoparticle fluorene copolymer silica photostability, Pharmaceuticals: Prosthetics and Medical Goods and other aspects.COA of Formula: C15H24O2

Lee, Chang-Soo; Chang, Hee Hyun; Jung, Juyeon; Lee, No Ah; Song, Nam Woong; Chung, Bong Hyun published an article in 2012, the title of the article was A novel fluorescent nanoparticle composed of fluorene copolymer core and silica shell with enhanced photostability.COA of Formula: C15H24O2 And the article contains the following content:

A variety of fluorescent nanoparticles have been developed for demanding applications such as optical biosensing and fluorescence imaging in live cells. Silica-based fluorescent nanoparticles offer diverse advantages for biol. applications. For example, they can be used as labeling probes due to their low toxicity, high sensitivity, resolution, and stability. In this research, a new class of highly fluorescent, efficient nanoparticles composed of a newly synthesized poly[di(2-methoxy-5-(2-ethylhexyloxy))-2,7-(9,9-dioctyl-9H-fluorene)] (PDDF) core and a silica shell (designated as PDDF@SiO2) were prepared using a simple reverse micelle method, and their fluorescent properties were evaluated using methods such as single-dot photoluminescence measurements. The enhanced photostability of the particles and their potential applications for bioanal. are discussed in this article. The morphol., size, and fluorescent properties for prepared PDDF@SiO2 nanoparticles were characterized using transmission electron microscopy (TEM), SEM (SEM) and photoluminescence spectroscopy. The prepared particles size, which was approx. 60 nm, resulted in an excellent colloidal stability in a physiol. environment. The photobleaching dynamics, total numbers of emitted photons (TNEP) and statistical measurements of individual nanoparticles were observed using laser scanning fluorescence microscopy to assess the structure and photostability of PDDF@SiO2 nanoparticles. Addnl., PDDF@SiO2 nanoparticles were used in cell toxicity and permeation tests for biol. analyses, demonstrating a great potential for use as powerful, novel materials within the emerging fields of biosensing and biomedical engineering. The experimental process involved the reaction of 1-((2-Ethylhexyl)oxy)-4-methoxybenzene(cas: 146370-51-6).COA of Formula: C15H24O2

The Article related to fluorescent nanoparticle fluorene copolymer silica photostability, Pharmaceuticals: Prosthetics and Medical Goods and other aspects.COA of Formula: C15H24O2

Referemce:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem

Li, Xiao-Chang Charles et al. published their patent in 2002 |CAS: 146370-51-6

The Article related to deuterated conjugated chromophore semiconductor, organic electroluminescent device deuterated conjugated chromophore semiconductor, Electric Phenomena: Semiconductor Junctions and Devices and other aspects.Recommanded Product: 146370-51-6

On June 13, 2002, Li, Xiao-Chang Charles; Ueno, Kazunori published a patent.Recommanded Product: 146370-51-6 The title of the patent was Deuterated semiconducting organic compounds used for optoelectronic devices. And the patent contained the following:

Organic semiconductors are described which comprise a linear conjugated organic compound or a polymer, a cyclic ring, a fused cyclic ring, a heterocyclic ring, a fused heterocyclic ring, a chelate or organometallic material described by the general formula CaMb (C = conjugated chromophore; M = Li, Na, K, Be, Mg, Ca, Ti, Cr, Mo, Mn, Fe, Ru, Os, Co, Rh, Ir, Ni, Pd, Pt, Cu, Zn, Cd, B, Al, Ga, In, Si, N, or P; and a and b = independently 1-10) wherein protons linked to the conjugated bonds are partially or fully deuterated. Preferably, the chromophore has ≥5 conjugated bonds. The semiconductor may be luminescent or promote energy transfer and it may have charge injection, hole blocking, or exciton blocking properties. Organic electroluminescent devices employing the semiconductors are also described. The experimental process involved the reaction of 1-((2-Ethylhexyl)oxy)-4-methoxybenzene(cas: 146370-51-6).Recommanded Product: 146370-51-6

The Article related to deuterated conjugated chromophore semiconductor, organic electroluminescent device deuterated conjugated chromophore semiconductor, Electric Phenomena: Semiconductor Junctions and Devices and other aspects.Recommanded Product: 146370-51-6

Referemce:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem

Sugimoto, Hachiro et al. published their research in Journal of Medicinal Chemistry in 1990 |CAS: 53136-21-3

The Article related to acetylcholinesterase inhibiting msbar benzylethylpiperidine, antidementia agent benzylethylpiperidine, dementia treatment agent benzylethylpiperidine, Heterocyclic Compounds (One Hetero Atom): Pyridines and other aspects.Recommanded Product: Benzyl(4-bromophenyl)sulfane

On July 31, 1990, Sugimoto, Hachiro; Tsuchiya, Yutaka; Sugumi, Hiroyuki; Higurashi, Kunizo; Karibe, Norio; Iimura, Yoichi; Sasaki, Atsushi; Kawakami, Yoshiyuki; Nakamura, Takaharu published an article.Recommanded Product: Benzyl(4-bromophenyl)sulfane The title of the article was Novel piperidine derivatives. Synthesis and anti-acetylcholinesterase activity of 1-benzyl-4-[2-(N-benzoylamino)ethyl]piperidine derivatives. And the article contained the following:

The title compound I (R = H, 2-Me, 4-NO2, 4-MeO, 4-CHO, 4-Cl, 4-PhCH2SO2; R1 = Bz, CH2Ph, CH2CH:CHPh, CH2CH2Ph, CH2C6H4Me-4, CH2C6H4NO2-2; R2 = H, Me, Et, Ph) were prepared and evaluated for antiacetylcholinesterase activity. Substituting the benzamide group with a bulky moiety in the para position led to a substantial increase in activity. Introduction of an alkyl or Ph group at the benzamide nitrogen atom dramatically enhanced the activity. The basicity of the piperidine nitrogen atom appears to play an important role in the increased activity, since the N-benzoylpiperidine derivative was almost inactive. I (R = 4-PhCH2SO2, R1 = CH2Ph, R2 = Me, R)(II) were the most potent inhibitors of acetylcholinesterase and produced significant increases in acetylcholine content in the cerebral cortex and hippocampus of rats. II was chosen for development as an antidementia agent. The experimental process involved the reaction of Benzyl(4-bromophenyl)sulfane(cas: 53136-21-3).Recommanded Product: Benzyl(4-bromophenyl)sulfane

The Article related to acetylcholinesterase inhibiting msbar benzylethylpiperidine, antidementia agent benzylethylpiperidine, dementia treatment agent benzylethylpiperidine, Heterocyclic Compounds (One Hetero Atom): Pyridines and other aspects.Recommanded Product: Benzyl(4-bromophenyl)sulfane

Referemce:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem

Biediger, Ronald J. et al. published their patent in 2018 |CAS: 66855-92-3

The Article related to propionic acid derivative propanoate pyridinylureido preparation alpha4 integrin inhibitor, Heterocyclic Compounds (One Hetero Atom): Pyridines and other aspects.HPLC of Formula: 66855-92-3

On November 15, 2018, Biediger, Ronald J.; Benish, Michele A.; Hardy, Lindsay Bonner; Boyd, Vincent A.; Market, Robert V.; Thrash, Thomas P.; Young, Brandon M. published a patent.HPLC of Formula: 66855-92-3 The title of the patent was Preparation of propionic acid derivatives as α4-integrin inhibitors. And the patent contained the following:

The title compounds I [R1 and R2 = (independently) H, halo, alkyl, cycloalkyl, or arylalkyl; R3 = hydroxy or oxido paired with a pharmaceutically acceptable cation.; R4 = hydroxy, alkoxy, or oxido paired with a pharmaceutically acceptable cation; R5 = (un)substituted Ph, aryl, heteroaryl or arylalkyl; X = CH2, O, or CF2; R6 = (un)substituted alkyl, Ph, aryl, heteroaryl] or pharmaceutically acceptable salts or stereoisomers thereof, useful for antagonizing the action of an α4-integrin to treat various pathophysiol. conditions, were prepared E.g., a multi-step synthesis of sodium 3-[3-(1,5-dimethyl-4-oxido-2-oxo-1,2-dihydropyridin-3-yl)ureido]-3-(3-phenoxyphenyl)propanoate (II), starting from Me propionylacetate and Me formate, was described. Exemplified compounds I were evaluated for their activities as α4-integrin inhibitors (data given for representative compounds I). Pharmaceutical composition comprising compound I was described. The experimental process involved the reaction of 3-(2-Methoxyphenoxy)benzaldehyde(cas: 66855-92-3).HPLC of Formula: 66855-92-3

The Article related to propionic acid derivative propanoate pyridinylureido preparation alpha4 integrin inhibitor, Heterocyclic Compounds (One Hetero Atom): Pyridines and other aspects.HPLC of Formula: 66855-92-3

Referemce:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem

Biediger, Ronald J. et al. published their patent in 2018 |CAS: 66855-92-3

The Article related to propionic acid derivative propanoate pyridinylureido preparation alpha4 integrin inhibitor, Heterocyclic Compounds (One Hetero Atom): Pyridines and other aspects.Application of 66855-92-3

On November 1, 2018, Biediger, Ronald J.; Benish, Michele A.; Market, Robert V.; Savage, Michael M.; Young, Brandon M. published a patent.Application of 66855-92-3 The title of the patent was Preparation of propionic acid derivatives as α4-integrin inhibitors. And the patent contained the following:

The title compounds I [R1 and R2 = (independently) H, halo, alkyl, cycloalkyl, or arylalkyl; R3 = hydroxy or oxido paired with a pharmaceutically acceptable cation.; R4 = hydroxy, alkoxy, or oxido paired with a pharmaceutically acceptable cation; R5 = (un)substituted Ph, aryl, heteroaryl or arylalkyl; X = CH2, O, or CF2; R6 = (un)substituted alkyl, Ph, aryl, heteroaryl] or pharmaceutically acceptable salts or stereoisomers thereof, useful for antagonizing the action of an α4-integrin to treat various pathophysiol. conditions, were prepared E.g., a multi-step synthesis of sodium 3-[3-(1,5-dimethyl-4-oxido-2-oxo-1,2-dihydropyridin-3-yl)ureido]-3-(3-phenoxyphenyl)propanoate (II), starting from Me propionylacetate and Me formate, was described. Exemplified compounds I were evaluated for their activities as α4-integrin inhibitors (data given for representative compounds I). Pharmaceutical composition comprising compound I was described. The experimental process involved the reaction of 3-(2-Methoxyphenoxy)benzaldehyde(cas: 66855-92-3).Application of 66855-92-3

The Article related to propionic acid derivative propanoate pyridinylureido preparation alpha4 integrin inhibitor, Heterocyclic Compounds (One Hetero Atom): Pyridines and other aspects.Application of 66855-92-3

Referemce:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem

Li, Yong et al. published their research in Journal of Medicinal Chemistry in 2022 |CAS: 66855-92-3

The Article related to amino beta carboline preparation antitumor sar pharmacokinetic human, Heterocyclic Compounds (One Hetero Atom): Pyridines and other aspects.Electric Literature of 66855-92-3

On February 10, 2022, Li, Yong; Liu, Yan; Zhu, Zejiang; Yan, Wei; Zhang, Chufeng; Yang, Zhuang; Bai, Peng; Tang, Minghai; Shi, Mingsong; He, Wen; Fu, Suhong; Liu, Jiang; Han, Kai; Li, Jiewen; Xie, Lixin; Ye, Haoyu; Yang, Jianhong; Chen, Lijuan published an article.Electric Literature of 66855-92-3 The title of the article was Structure-Based Design and Synthesis of N-Substituted 3-Amino-β-Carboline Derivatives as Potent αβTubulin Degradation Agents. And the article contained the following:

Compound I, a noncovalent colchicine-site ligand, was capable of promoting αβ-tubulin degradation was found in previous studies. To further improve its antiproliferative activity, derivatives or analogs II [R1 = n-Pr, n-Bu, cyclopentyl, etc.], III [R3 = Et, 2-FC6H4, 3-pyridyl, etc.] of compound I were designed and synthesized based on 2-tubulin cocrystal structure. Among them, compound III [R3 = 1,3-benzodioxol-5-yl] displayed nanomolar potency against a variety of tumor cells, including paclitaxel- and adriamycin-resistant cell lines. Compound III [R3 = 1,3-benzodioxol-5-yl] binds to the colchicine site and promotes αβ-tubulin degradation in a concentration-dependent manner via the ubiquitin-proteasome pathway. The X-ray crystal structure revealed that compound III [R3 = 1,3-benzodioxol-5-yl] binds in a similar manner as compound I, but there was a slight conformation change of the B ring, which resulted in better interaction of compound III [R3 = 1,3-benzodioxol-5-yl] with surrounding residues. Compound III [R3 = 1,3-benzodioxol-5-yl] effectively suppressed tumor growth at an i.v. dose of 40 mg/kg (3 times a week) on both A2780S (paclitaxel-sensitive) and A2780T (paclitaxel-resistant) ovarian xenograft models, with resp. TGIs of 92.42 and 79.75% without obvious side effects, supporting its potential utility as a tumor-therapeutic compound The experimental process involved the reaction of 3-(2-Methoxyphenoxy)benzaldehyde(cas: 66855-92-3).Electric Literature of 66855-92-3

The Article related to amino beta carboline preparation antitumor sar pharmacokinetic human, Heterocyclic Compounds (One Hetero Atom): Pyridines and other aspects.Electric Literature of 66855-92-3

Referemce:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem

Yang, Chunhe et al. published their research in Synthetic Metals in 2001 |CAS: 146370-51-6

The Article related to polymer light emitting electrochem cell methoxyethylhexyloxybenzene, Electrochemistry: Electrochemical Cells and Systems and other aspects.SDS of cas: 146370-51-6

On October 22, 2001, Yang, Chunhe; He, Gufeng; Sun, Qingjiang; Li, Yongfang published an article.SDS of cas: 146370-51-6 The title of the article was Polymer light-emitting electrochemical cells with 1-methoxy-4-(2-ethylhexyloxy)benzene as salt carrier. And the article contained the following:

The electro-active, 1-methoxy-4-(2-ethylhexyloxy)benzene (MEH-benzene) is employed as ion carrier and redox shuttle in the polymer light-emitting electrochem. cell (LEC). The corresponding LECs with MEH-PPV can be driven within 10 V without failure. The LEC characteristics are clearly shown by the current-voltage curves and the ac impedance spectroscopy. The experimental process involved the reaction of 1-((2-Ethylhexyl)oxy)-4-methoxybenzene(cas: 146370-51-6).SDS of cas: 146370-51-6

The Article related to polymer light emitting electrochem cell methoxyethylhexyloxybenzene, Electrochemistry: Electrochemical Cells and Systems and other aspects.SDS of cas: 146370-51-6

Referemce:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem

Luo, Shuping et al. published their patent in 2021 |CAS: 53136-21-3

The Article related to aryl sulfide compound preparation photocatalysis, Heterocyclic Compounds (One Hetero Atom): Pyridines and other aspects.Recommanded Product: Benzyl(4-bromophenyl)sulfane

On April 2, 2021, Luo, Shuping; Wang, Tianqi; Liu, Xiaoqing; Ren, Chenchao; Zhang, Yu published a patent.Recommanded Product: Benzyl(4-bromophenyl)sulfane The title of the patent was Photocatalytic preparation of aryl sulfide and its derivatives. And the patent contained the following:

The present invention relates to the photocatalytic preparation of aryl sulfide and its derivatives In particular, the aryl sulfide compound I or II (wherein, Ar = substituent-substituted Ph group, substituent-substituted benzyl group or substituent-substituted naphthyl group, and the substituent = H, C1-C4 alkyl, C1-C4 alkoxy, halogen group or nitro group; R = H, Me or halogen group; X = C, S, N or O) was prepared by dissolving an N-(sulfanyl) amide compound in a Me aromatic compound under inert gas protection condition, under the action of light, a catalyst, a ligand and a base. The inventive method has good functional group compatibility, the C-S bond compound can be selectively and efficiently constructed in one step, has simple catalytic system, mild reaction conditions, simple and accessible substrate economy and simple reaction operation. The experimental process involved the reaction of Benzyl(4-bromophenyl)sulfane(cas: 53136-21-3).Recommanded Product: Benzyl(4-bromophenyl)sulfane

The Article related to aryl sulfide compound preparation photocatalysis, Heterocyclic Compounds (One Hetero Atom): Pyridines and other aspects.Recommanded Product: Benzyl(4-bromophenyl)sulfane

Referemce:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem

Zhao, Lifeng et al. published their research in Huazhong Shifan Daxue Xuebao, Ziran Kexueban in 2012 |CAS: 146370-51-6

The Article related to poly phenylene vinylene synthesis characterization photophysic, Optical, Electron, and Mass Spectroscopy and Other Related Properties: Electronic Spectroscopy and other aspects.Application In Synthesis of 1-((2-Ethylhexyl)oxy)-4-methoxybenzene

On February 29, 2012, Zhao, Lifeng; Li, Shengbiao; Tao, Haiyan; Su, Jinjin; Wang, Zhenjiang; Wang, Hongli; Huang, Wei published an article.Application In Synthesis of 1-((2-Ethylhexyl)oxy)-4-methoxybenzene The title of the article was Novel hyperbranched poly (phenylene vinylene) s containing four arms: Synthesis, characterization and properties of photophysics. And the article contained the following:

Novel PPVs derivates were designed and successfully synthesized through Gilch reaction. The reaction intermediates and polymers were characterized by 1H NMR, GC-MS or GPC and Elemental Anal. (EA). Their optical properties, thermal properties, electrochem. properties were investigated. These polymers were soluble in common organic solvents and they have good thermal stability. The onset weights loss temperature of the three polymers were found to be 371.7, 386.6 and 391.8掳C for P1, P2 and P3, resp. Compared with their spectra absorption in chloroform, the absorption bands of polymers P1, P2 and P3 in thin films were red-shifted. These polymers would be promising materials for luminescent materials or solar cells. The experimental process involved the reaction of 1-((2-Ethylhexyl)oxy)-4-methoxybenzene(cas: 146370-51-6).Application In Synthesis of 1-((2-Ethylhexyl)oxy)-4-methoxybenzene

The Article related to poly phenylene vinylene synthesis characterization photophysic, Optical, Electron, and Mass Spectroscopy and Other Related Properties: Electronic Spectroscopy and other aspects.Application In Synthesis of 1-((2-Ethylhexyl)oxy)-4-methoxybenzene

Referemce:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem

Kwon, Hyung Ki et al. published their patent in 2000 |CAS: 146370-51-6

The Article related to electroluminescent device blue light emitting compound, display electroluminescent device, anthracene derivative electroluminescent compound, Radiation Chemistry, Photochemistry, and Photographic and Other Reprographic Processes: Other and other aspects.Related Products of 146370-51-6

On May 23, 2000, Kwon, Hyung Ki; Kim, Yoon Hee; Shin, Dong Chul; Yoo, Han Sung; Cho, Sung Woo; Kim, Dong Geun; Cho, Sung Gun published a patent.Related Products of 146370-51-6 The title of the patent was Blue light-emitting compounds, light-emitting elements, and light-emitting display devices. And the patent contained the following:

Light-emitting compounds I [Ar1-5 = (un)substituted Ph, naphthalene, anthracene, diphenylanthracene, phenanthrene, indene, acenaphthene, biphenyl, fluorene, carbazole, thiophene, pyridine, oxadiazole, oxazole, triazole, benzothiophene, dibenzofuran, thiadiazole; R1-4 = H, ethylenoxy, C1-20 alkyl, C1-20 alkoxy, aryl, trimethylsilyl, trimethylsilylaryl, cyano] are claimed. Further specifications of Ar1-5 are also given. Light-emitting elements and displays comprising the compounds are also claimed. Blue light-emitting elements showing high luminosity are obtained. The experimental process involved the reaction of 1-((2-Ethylhexyl)oxy)-4-methoxybenzene(cas: 146370-51-6).Related Products of 146370-51-6

The Article related to electroluminescent device blue light emitting compound, display electroluminescent device, anthracene derivative electroluminescent compound, Radiation Chemistry, Photochemistry, and Photographic and Other Reprographic Processes: Other and other aspects.Related Products of 146370-51-6

Referemce:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem